Pages that link to "Q38118187"

The following pages link to Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator (Q38118187):

Displaying 38 items.

• Glial Modulation by N-acylethanolamides in Brain Injury and Neurodegeneration (Q26747533) (← links)
• Antineuropathic profile of N-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicity (Q27305830) (← links)
• Palmitoylethanolamide induces microglia changes associated with increased migration and phagocytic activity: involvement of the CB2 receptor (Q33671206) (← links)
• Dopaminergic Toxin 1-Methyl-4-Phenylpyridinium, Proteins α-Synuclein and Glia Maturation Factor Activate Mast Cells and Release Inflammatory Mediators (Q35746518) (← links)
• Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice. (Q35939665) (← links)
• Effect of a new formulation of micronized and ultramicronized N-palmitoylethanolamine in a tibia fracture mouse model of complex regional pain syndrome (Q36395889) (← links)
• Co-micronized Palmitoylethanolamide/Polydatin Treatment Causes Endometriotic Lesion Regression in a Rodent Model of Surgically Induced Endometriosis. (Q37338638) (← links)
• Involvement of the endocannabinoid system in the physiological response to transient common carotid artery occlusion and reperfusion. (Q37595794) (← links)
• Safety of micronized palmitoylethanolamide (microPEA): lack of toxicity and genotoxic potential (Q37675145) (← links)
• The neuroprotective effect exerted by oligodendroglial progenitors on ischemically impaired hippocampal cells (Q38256533) (← links)
• Myeloid Cells in the Central Nervous System (Q39388337) (← links)
• Brain and Peripheral Atypical Inflammatory Mediators Potentiate Neuroinflammation and Neurodegeneration (Q41097407) (← links)
• Delay of morphine tolerance by palmitoylethanolamide (Q41908176) (← links)
• Increased levels of palmitoylethanolamide and other bioactive lipid mediators and enhanced local mast cell proliferation in canine atopic dermatitis (Q41953638) (← links)
• Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain. (Q42176106) (← links)
• Palmitoylethanolamide Reduces Neuropsychiatric Behaviors by Restoring Cortical Electrophysiological Activity in a Mouse Model of Mild Traumatic Brain Injury. (Q42318251) (← links)
• Glia activation and its role in oxidative stress. (Q46972859) (← links)
• Cross-Talk between Glia, Neurons and Mast Cells in Neuroinflammation Associated with Parkinson's Disease. (Q47738283) (← links)
• Acute administration of beta-caryophyllene prevents endocannabinoid system activation during transient common carotid artery occlusion and reperfusion (Q48103877) (← links)
• Ultramicronized palmitoylethanolamide counteracts the effects of compound 48/80 in a canine skin organ culture model. (Q48323713) (← links)
• Clemastine Confers Neuroprotection and Induces an Anti-Inflammatory Phenotype in SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis. (Q48421588) (← links)
• Antiepileptogenic Effect of Subchronic Palmitoylethanolamide Treatment in a Mouse Model of Acute Epilepsy. (Q52316988) (← links)
• Oral Ultramicronized Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect. (Q52608759) (← links)
• N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception. (Q55094909) (← links)
• Micronized palmitoylethanolamide reduces joint pain and glial cell activation (Q56342104) (← links)
• Localization of cannabinoid receptors CB1, CB2, GPR55, and PPARα in the canine gastrointestinal tract (Q56379613) (← links)
• Efficacy of ultramicronized palmitoylethanolamide in burning mouth syndrome-affected patients: a preliminary randomized double-blind controlled trial (Q58554395) (← links)
• Palmitoylethanolamide prevents neuroinflammation, reduces astrogliosis and preserves recognition and spatial memory following induction of neonatal anoxia-ischemia (Q60714197) (← links)
• Oleoylethanolamide, Neuroinflammation, and Alcohol Abuse (Q61449859) (← links)
• The Role of Mast Cells in Stroke. (Q64902515) (← links)
• Cellular Distribution of Canonical and Putative Cannabinoid Receptors in Canine Cervical Dorsal Root Ganglia (Q90682483) (← links)
• Combining a joint health supplement with tibial plateau leveling osteotomy in dogs with cranial cruciate ligament rupture. An exploratory controlled trial (Q91744212) (← links)
• Altered Metabolism of Phospholipases, Diacylglycerols, Endocannabinoids, and N-Acylethanolamines in Patients with Mastocytosis (Q92243934) (← links)
• Mast Cells, Neuroinflammation and Pain in Fibromyalgia Syndrome (Q92711498) (← links)
• Molecular Targets of Fatty Acid Ethanolamides in Asthma (Q92795215) (← links)
• Effect of dietary supplementation with ultramicronized palmitoylethanolamide in maintaining remission in cats with nonflea hypersensitivity dermatitis: a double-blind, multicentre, randomized, placebo-controlled study (Q93008031) (← links)
• Effect of palmitoylethanolamide on inner retinal function in glaucoma: a randomized, single blind, crossover, clinical trial by pattern-electroretinogram (Q96765623) (← links)
• Wikidata:WikiProject Chronic Pain/Neuroglia (← links | edit)